V. Cogliano, Y. Grosse, and R. Baan, Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment, The Lancet Oncology, vol.6, issue.8, pp.552-553, 2005.
DOI : 10.1016/S1470-2045(05)70273-4

W. Anderson, K. Chu, and S. Chang, Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma, Cancer Epidemiol Biomarkers Prev, vol.13, pp.1128-1135, 2004.

C. Li, J. Daling, and K. Malone, Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.5, pp.946-954, 2006.
DOI : 10.1158/1055-9965.EPI-05-0881

H. Ma, L. Bernstein, and M. Pike, Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies, Breast Cancer Research, vol.15, issue.4, p.43, 2006.
DOI : 10.1016/j.tem.2004.05.011

S. Lee, R. Ross, and M. Pike, An overview of menopausal oestrogen???progestin hormone therapy and breast cancer risk, British Journal of Cancer, vol.151, issue.11, pp.2049-2058, 2005.
DOI : 10.1016/S0029-7844(02)02502-4

A. Fournier, F. Berrino, and F. Clavel-chapelon, Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study, Breast Cancer Research and Treatment, vol.95, issue.1, pp.103-111, 2008.
DOI : 10.1007/s10549-007-9523-x
URL : https://hal.archives-ouvertes.fr/inserm-00201813

C. Li, B. Anderson, and P. Porter, Changing incidence rate of invasive lobular breast carcinoma among older women, Cancer, vol.50, issue.11, pp.2561-2569, 2000.
DOI : 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X

C. Li, B. Anderson, and J. Daling, Trends in Incidence Rates of Invasive Lobular and Ductal Breast Carcinoma, JAMA, vol.289, issue.11, pp.1421-1424, 2003.
DOI : 10.1001/jama.289.11.1421

F. Levi, V. Te, and L. Randimbison, Increase in lobular breast cancer incidence in Switzerland, International Journal of Cancer, vol.39, issue.1, pp.164-165, 2003.
DOI : 10.1002/ijc.11309

H. Verkooijen, G. Fioretta, and G. Vlastos, Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland, International Journal of Cancer, vol.8, issue.6, pp.778-781, 2003.
DOI : 10.1002/ijc.11032

H. Verkooijen, V. Koot, and G. Fioretta, Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations, Breast Cancer Research and Treatment, vol.6, issue.3, pp.389-395, 2008.
DOI : 10.1007/s10549-007-9554-3

C. Li, N. Weiss, and J. Stanford, Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women, Cancer, vol.128, issue.11, pp.2570-2577, 2000.
DOI : 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O

G. Ursin, C. Tseng, and A. Paganini-hill, Does Menopausal Hormone Replacement Therapy Interact With Known Factors to Increase Risk of Breast Cancer?, Journal of Clinical Oncology, vol.20, issue.3, pp.699-706, 2002.
DOI : 10.1200/JCO.2002.20.3.699

C. Chen, N. Weiss, and P. Newcomb, Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-741, 2002.
DOI : 10.1001/jama.287.6.734

J. Daling, K. Malone, and D. Doody, Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma, Cancer, vol.73, issue.12, pp.2455-2464, 2002.
DOI : 10.1002/cncr.10984

P. Newcomb, L. Titus-ernstoff, and K. Egan, Postmenopausal estrogen and progestin use in relation to breast cancer risk, Cancer Epidemiol Biomarkers Prev, vol.11, pp.593-600, 2002.

L. Newcomer, P. Newcomb, and J. Potter, Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States), Cancer Causes and Control, vol.14, issue.3, pp.225-233, 2003.
DOI : 10.1023/A:1023634907723

C. Li, K. Malone, and P. Porter, Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer, JAMA, vol.289, issue.24, pp.3254-3263, 2003.
DOI : 10.1001/jama.289.24.3254

R. Chlebowski, S. Hendrix, and R. Langer, Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, JAMA, vol.289, issue.24, pp.3243-3253, 2003.
DOI : 10.1001/jama.289.24.3243

S. Lee, L. Kolonel, and L. Wilkens, Postmenopausal hormone therapy and breast cancer risk: The multiethnic cohort, International Journal of Cancer, vol.289, issue.5, pp.1285-1291, 2006.
DOI : 10.1002/ijc.21481

M. Garcia-closas, L. Brinton, and J. Lissowska, Established breast cancer risk factors by clinically important tumour characteristics, British Journal of Cancer, vol.150, issue.1, pp.123-129, 2006.
DOI : 10.1023/A:1008970121595

L. Rosenberg, C. Magnusson, and E. Lindstrom, Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study, Breast Cancer Research, vol.91, issue.2, p.11, 2006.
DOI : 10.1093/jnci/91.13.1131

G. Reeves, V. Beral, and J. Green, Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis, The Lancet Oncology, vol.7, issue.11, pp.910-918, 2006.
DOI : 10.1016/S1470-2045(06)70911-1

S. Borgquist, L. Anagnostaki, and K. Jirstrom, Breast tumours following combined hormone replacement therapy express favourable prognostic factors, International Journal of Cancer, vol.289, issue.10, pp.2202-2207, 2007.
DOI : 10.1002/ijc.22542

N. Hildreth, J. Kelsey, and A. Eisenfeld, Differences in breast cancer risk factors according to the estrogen receptor level of the tumor, J Natl Cancer Inst, vol.70, pp.1027-1031, 1983.

J. Stanford, M. Szklo, and C. Boring, A CASE-CONTROL STUDY OF BREAST CANCER STRATIFIED BY ESTROGEN RECEPTOR STATUS, American Journal of Epidemiology, vol.125, issue.2, pp.184-194, 1987.
DOI : 10.1093/oxfordjournals.aje.a114519

J. Cooper, T. Rohan, and E. Cant, Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study, British Journal of Cancer, vol.59, issue.1, pp.119-125, 1989.
DOI : 10.1038/bjc.1989.24

J. Potter, J. Cerhan, and T. Sellers, Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: How many kinds of breast cancer are there?, Cancer Epidemiol Biomarkers Prev, vol.4, pp.319-326, 1995.

W. Huang, B. Newman, and R. Millikan, Hormone-related Factors and Risk of Breast Cancer in Relation to Estrogen Receptor and Progesterone Receptor Status, American Journal of Epidemiology, vol.151, issue.7, pp.703-714, 2000.
DOI : 10.1093/oxfordjournals.aje.a010265

K. Kerlikowske, D. Miglioretti, and R. Ballard-barbash, Prognostic Characteristics of Breast Cancer Among Postmenopausal Hormone Users in a Screened Population, Journal of Clinical Oncology, vol.21, issue.23, pp.4314-4321, 2003.
DOI : 10.1200/JCO.2003.05.151

M. Cotterchio, N. Kreiger, and B. Theis, Hormonal factors and the risk of breast cancer according to estrogen-and progesterone-receptor subgroup, Cancer Epidemiol Biomarkers Prev, vol.12, pp.1053-1060, 2003.

C. Stahlberg, A. Pedersen, and Z. Andersen, Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy, British Journal of Cancer, vol.11, pp.644-650, 2004.
DOI : 10.1200/JCO.20.3.699

W. Chen, S. Hankinson, and S. Schnitt, Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma, Cancer, vol.98, issue.7, pp.1490-1500, 2004.
DOI : 10.1002/cncr.20499

A. Tjonneland, J. Christensen, and B. Thomsen, Hormone replacement therapy in relation to breast carcinoma incidence rate ratios, Cancer, vol.80, issue.11, pp.2328-2337, 2004.
DOI : 10.1002/cncr.20250

M. Stefanick, G. Anderson, and K. Margolis, Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With Hysterectomy, JAMA, vol.295, issue.14, pp.1647-1657, 2006.
DOI : 10.1001/jama.295.14.1647

L. Rosenberg, K. Einarsdottir, and E. Friman, Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.12, pp.2482-2488, 2006.
DOI : 10.1158/1055-9965.EPI-06-0489

C. Antoine, F. Liebens, and C. B. , Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial, Human Reproduction, vol.19, issue.3, pp.741-756, 2004.
DOI : 10.1093/humrep/deh112

E. Riboli, K. Hunt, and N. Slimani, European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection, Public Health Nutrition, vol.59, issue.6b, pp.1113-1124, 2002.
DOI : 10.1093/ije/26.suppl_1.S1

N. Weiss and M. Rossing, Healthy screened bias in epidemiologic studies of cancer incidence, Epidemiology, vol.7, pp.319-322, 1996.

S. Lagakos, A Covariate Model for Partially Censored Data Subject to Competing Causes of Failure, Applied Statistics, vol.27, issue.3, pp.235-241, 1978.
DOI : 10.2307/2347158

C. Li, D. Uribe, and J. Daling, Clinical characteristics of different histologic types of breast cancer, British Journal of Cancer, vol.57, issue.9, pp.1046-1052, 2005.
DOI : 10.1023/A:1023634907723

B. Rockhill, G. Colditz, and B. Rosner, Bias in Breast Cancer Analyses Due to Error in Age at Menopause, American Journal of Epidemiology, vol.151, issue.4, pp.404-408, 2000.
DOI : 10.1093/oxfordjournals.aje.a010220

M. Pike, R. Ross, and D. Spicer, Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk, American Journal of Epidemiology, vol.147, issue.8, pp.718-721, 1998.
DOI : 10.1093/oxfordjournals.aje.a009515

C. Campagnoli, F. Clavel-chapelon, and R. Kaaks, Progestins and progesterone in hormone replacement therapy and the risk of breast cancer, The Journal of Steroid Biochemistry and Molecular Biology, vol.96, issue.2, pp.95-108, 2005.
DOI : 10.1016/j.jsbmb.2005.02.014
URL : https://hal.archives-ouvertes.fr/inserm-00151947

J. Pasqualini, J. Paris, and R. Sitruk-ware, Progestins and breast cancer, The Journal of Steroid Biochemistry and Molecular Biology, vol.65, issue.1-6, pp.225-235, 1998.
DOI : 10.1016/S0960-0760(98)00028-4

F. Stanczyk, All progestins are not created equal, Steroids, vol.68, issue.10-13, pp.879-890, 2003.
DOI : 10.1016/j.steroids.2003.08.003

R. Santen, Risk of breast cancer with progestins: critical assessment of current data, Steroids, vol.68, issue.10-13, pp.953-964, 2003.
DOI : 10.1016/S0039-128X(03)00138-7

D. Ferguson and T. Anderson, Morphological evaluation of cell turnover in relation to the menstrual cycle in the ???resting??? human breast, British Journal of Cancer, vol.44, issue.2, pp.177-181, 1981.
DOI : 10.1038/bjc.1981.168

T. Longacre and S. Bartow, A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle, The American Journal of Surgical Pathology, vol.10, issue.6, pp.382-393, 1986.
DOI : 10.1097/00000478-198606000-00003

K. Chang, T. Lee, and G. Linares-cruz, Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo**Supported by Besins-Iscovesco, Paris, France and Orient Europharma, Taipei, Taiwan.??????Presented in part at the 7th International Congress on the Menopause, Stockholm, Sweden, June 20 to 24, 1993., Fertility and Sterility, vol.63, issue.4, pp.785-791, 1995.
DOI : 10.1016/S0015-0282(16)57482-2

J. Foidart, C. Colin, and X. Denoo, Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells, Fertility and Sterility, vol.69, issue.5, pp.963-969, 1998.
DOI : 10.1016/S0015-0282(98)00042-9

L. Hofseth, A. Raafat, and J. Osuch, Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation in the Normal Postmenopausal Breast, Journal of Clinical Endocrinology & Metabolism, vol.84, issue.12, pp.4559-4565, 1999.
DOI : 10.1210/jc.84.12.4559

J. Cline, G. Soderqvist, V. Schoultz, and E. , Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques, American Journal of Obstetrics and Gynecology, vol.174, issue.1, pp.93-100, 1996.
DOI : 10.1016/S0002-9378(96)70379-4

C. Wood, T. Register, and C. Lees, Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys, Breast Cancer Research and Treatment, vol.280, issue.2, pp.125-134, 2007.
DOI : 10.1007/s10549-006-9276-y

E. Anderson, Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis, Breast Cancer Research, vol.72, issue.5, pp.197-201, 2002.
DOI : 10.1023/A:1014820500738

P. Ravdin, K. Cronin, and N. Howlader, The Decrease in Breast-Cancer Incidence in 2003 in the United States, New England Journal of Medicine, vol.356, issue.16, pp.1670-1674, 2007.
DOI : 10.1056/NEJMsr070105

R. Clarke, Ovarian steroids and the human breast: Regulation of stem cells and cell proliferation, Maturitas, vol.54, issue.4, pp.327-334, 2006.
DOI : 10.1016/j.maturitas.2006.06.002

R. Prasad, G. Boland, and A. Cramer, Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma, Cancer, vol.94, issue.12, pp.2539-2546, 2003.
DOI : 10.1002/cncr.11836

J. Botella, E. Duranti, and I. Duc, Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells, The Journal of Steroid Biochemistry and Molecular Biology, vol.50, issue.1-2, pp.41-47, 1994.
DOI : 10.1016/0960-0760(94)90170-8

L. Wei, N. Krett, and M. Francis, Multiple Human Progesterone Receptor Messenger Ribonucleic Acids and Their Autoregulation by Progestin Agonists and Antagonists in Breast Cancer Cells, Molecular Endocrinology, vol.2, issue.1, pp.62-72, 1988.
DOI : 10.1210/mend-2-1-62

X. Cui, P. Zhang, and W. Deng, Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast Cancer, Molecular Endocrinology, vol.17, issue.4, pp.575-588, 2003.
DOI : 10.1210/me.2002-0318

K. Holli, J. Isola, and J. Cuzick, Low biologic aggressiveness in breast cancer in women using hormone replacement therapy., Journal of Clinical Oncology, vol.16, issue.9, pp.3115-3120, 1998.
DOI : 10.1200/JCO.1998.16.9.3115

I. Pappo, I. Meirshon, and T. Karni, The Characteristics of Malignant Breast Tumors in Hormone Replacement Therapy Users Versus Nonusers, Annals of Surgical Oncology, vol.11, issue.1, pp.52-58, 2004.
DOI : 10.1245/ASO.2004.03.012

N. Biglia, L. Sgro, and E. Defabiani, The influence of hormone replacement therapy on the pathology of breast cancer, European Journal of Surgical Oncology (EJSO), vol.31, issue.5, pp.467-472, 2005.
DOI : 10.1016/j.ejso.2005.02.005

C. Lange, J. Richer, and T. Shen, Convergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer: POTENTIATION OF MITOGEN-ACTIVATED PROTEIN KINASE PATHWAYS, Journal of Biological Chemistry, vol.273, issue.47, pp.31308-31316, 1998.
DOI : 10.1074/jbc.273.47.31308

A. Carvajal, N. Espinoza, and S. Kato, Progesterone Pre-treatment Potentiates EGF Pathway Signaling in The Breast Cancer Cell Line ZR-75*, Breast Cancer Research and Treatment, vol.6, issue.2, pp.171-183, 2005.
DOI : 10.1007/s10549-005-7726-6

L. Murphy, R. Sutherland, and B. Stead, Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells, Cancer Res, vol.46, pp.728-734, 1986.